Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF IssuersUBSCHSRI
CHSRI

UBS MSCI Switzerland IMI Socially Responsible ETF

The CHSRI Exchange Traded Fund (ETF) is provided by UBS. It is built to track an index: MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Index. The CHSRI ETF provides physical exposure, so by buying it you actually own parts of all the 63 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

CHF 19.74
+CHF 0.068 (+0.35%) 2 days ago
7:00 AM 09/11/26 Closed
1D price range
CHF 19.71CHF 19.83
52W price range
CHF 17.28CHF 21.00
YTD Perf.
+5.65%
YTD Flows
Annualized volatility
Fund AuM
€461M
Share class AuM
€237M
TTM Yield
Tracking Error
Tracking Difference
ISIN
CH0368190739
TER
0.28%
Inception date
9/11/2017
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Sep 10, 2026
-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
29.76%
Finance
28.97%
Non-Energy Materials
11.15%
Industrials
10.72%
Consumer Non-Cyclicals
8.26%
Technology
4.33%
Business Services
3.20%
Telecommunications
2.73%
Other
0.82%
Latest CHSRI news

No content available for this fund

FAQ about CHSRI

CHSRI is a Passive ETF. This ETF provides exposure to Other Swiss Equities.
CHSRI tracks the MSCI Switzerland IMI Extended SRI Low Carbon Select 5% Issuer Capped Net Total Return Index - CHF, through a full replication replication method.
CHSRI carries a total expense ratio (TER) of 0.28%, indicating the annual cost for holding the fund.
CHSRI was introduced to the market on September 11, 2017. It trades on Liechtenstein, among other exchanges
UBS MSCI Switzerland IMI Socially Responsible ETF, CHSRI, is provided by UBS. Learn more about UBS here.
CHSRI oversees €237M in assets as of September 10, 2026.
CHSRI follows a distributing dividend policy, meaning it pays out income to investors. As of September 10, 2026, its 12-month trailing yield was 2.12%.
As of July 31, 2026, CHSRI has significant geographic allocations in Switzerland.
As of July 31, 2026, CHSRI focuses largely on Healthcare, Finance and Non-Energy Materials.
As of July 31, 2026, CHSRI holds 63 positions in its portfolio, with 64.84% of assets concentrated in its top 15 holdings.
As of July 31, 2026, CHSRI top three holdings include UBS Group AG, Swiss Re AG and Zurich Insurance Group AG.
The base currency of CHSRI is CHF.
Data as of 07/31/26
UBS Group AG
5.52%
Swiss Re AG
5.05%
Zurich Insurance Group AG
5.04%
Roche Holding AG
5.03%
Novartis AG
4.98%
Nestlé SA
4.75%
Galderma Group AG
4.70%
ABB Ltd.
4.68%
Givaudan SA
4.32%
Sika AG
4.02%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight